Integrated BioPharma, Inc. (OTCMKTS:INBP) Short Interest Up 2,500.0% in October

Integrated BioPharma, Inc. (OTCMKTS:INBP) saw a significant increase in short interest in the month of October. As of October 31st, there was short interest totalling 5,200 shares, an increase of 2,500.0% from the October 15th total of 200 shares. Based on an average daily trading volume, of 51,200 shares, the short-interest ratio is currently 0.1 days.

Integrated BioPharma Stock Performance

Shares of INBP stock remained flat at $0.33 on Tuesday. The business has a 50-day simple moving average of $0.25 and a 200 day simple moving average of $0.22. Integrated BioPharma has a 52-week low of $0.16 and a 52-week high of $0.35. The firm has a market cap of $9.92 million, a PE ratio of 33.00 and a beta of 0.62.

Integrated BioPharma (OTCMKTS:INBP) last released its earnings results on Friday, September 20th. The company reported $0.01 EPS for the quarter. Integrated BioPharma had a return on equity of 0.59% and a net margin of 0.22%. The business had revenue of $12.75 million during the quarter.

About Integrated BioPharma

Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers.